<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01774422</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0136</org_study_id>
    <secondary_id>2012-A01159-34</secondary_id>
    <nct_id>NCT01774422</nct_id>
  </id_info>
  <brief_title>Use of the Medical Device DECAP CO2 for the Treatment of Hypercapnic Respiratory Distress in Patients Under Noninvasive Ventilation</brief_title>
  <acronym>DECAP CO2</acronym>
  <official_title>Use of the Medical Device DECAP CO2 for the Treatment of Hypercapnic Respiratory Distress in Patients Under Noninvasive Ventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <brief_summary>
    <textblock>
      The patients affected by severe chronic respiratory failure can develop hypercapnic&#xD;
      decompensation leading to coma and death in a few hours. At present, the main treatment is&#xD;
      noninvasive or invasive ventilation. The noninvasive invasive ventilation requires a minimum&#xD;
      of consciousness to insure spontaneous ventilation. In case of noninvasive ventilation&#xD;
      impossibility, invasive mechanical ventilation is proposed to patients, which is an&#xD;
      aggressive therapy. Regularly, the patients undergo this aggressive therapy without having&#xD;
      expressed their opinion. Indeed, a great majority of these patients with severe respiratory&#xD;
      insufficiency did not anticipate directives in case of respiratory decompensation&#xD;
      (acceptation of aggressive treatments). Efficiency of these aggressive therapies is still&#xD;
      uncertain but certainly alters quality of life (discomfort, loss of autonomyâ€¦). After&#xD;
      complete, clear, loyal and adapted information, a majority of patient do not wish to go on&#xD;
      these aggressive therapies. At the time of the decompensation, the patients are incapable to&#xD;
      express an opinion because of the hypercapnic narcosis. An extracorporeal CO2 remover device,&#xD;
      such as the DECAP CO2, would quickly decrease the hypercapnia what would allow the patient to&#xD;
      improve his state of consciousness and so to find the conditions of spontaneous ventilation&#xD;
      required for the noninvasive ventilation. The DECAP CO2 device can be used to stop quickly&#xD;
      the hypercapnic narcosis and to collect the wills of the patient on the choice of possible&#xD;
      aggressive therapies. It is in this last condition that we wish to estimate the DECAP CO2&#xD;
      device.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After validation of the inclusion and exclusion criteria, the patients include in this&#xD;
      clinical trial will be randomized between the two arms of the study:&#xD;
&#xD;
        -  Noninvasive ventilation alone&#xD;
&#xD;
        -  Noninvasive ventilation associated with the DECAP CO2 device&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hypercapnia</measure>
    <time_frame>H24</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>H0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of judgment disability</measure>
    <time_frame>H72</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of blood pH normalization</measure>
    <time_frame>H72</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hypercapnia</measure>
    <time_frame>H72</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glasgow</measure>
    <time_frame>H0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SAPSII scores(Simplified Acute Physiology Score II)</measure>
    <time_frame>H24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of noninvasive ventilation</measure>
    <time_frame>H72</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization</measure>
    <time_frame>H72</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>H72</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MMSE (Mini Mental State Examination)</measure>
    <time_frame>H0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ACE ( Aid To Capacity Evaluation)scores</measure>
    <time_frame>H0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA scores(Sepsis-related Organ )</measure>
    <time_frame>H24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>H1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>H2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>H3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>H4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>H6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>H12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>H18</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Gases</measure>
    <time_frame>H24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>H32</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>H40</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>H48</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>H56</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>H64</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases</measure>
    <time_frame>H72</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glasgow</measure>
    <time_frame>H4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glasgow</measure>
    <time_frame>H8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glasgow</measure>
    <time_frame>H24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glasgow</measure>
    <time_frame>H36</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glasgow</measure>
    <time_frame>H48</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MMSE (Mini Mental State Examination)</measure>
    <time_frame>H4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MMSE (Mini Mental State Examination)</measure>
    <time_frame>H8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MMSE (Mini Mental State Examination)</measure>
    <time_frame>H24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MMSE (Mini Mental State Examination)</measure>
    <time_frame>H36</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MMSE (Mini Mental State Examination)</measure>
    <time_frame>H48</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ACE ( Aid To Capacity Evaluation)scores</measure>
    <time_frame>H4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ACE ( Aid To Capacity Evaluation)scores</measure>
    <time_frame>H8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ACE ( Aid To Capacity Evaluation)scores</measure>
    <time_frame>H24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ACE ( Aid To Capacity Evaluation)scores</measure>
    <time_frame>H36</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ACE ( Aid To Capacity Evaluation)scores</measure>
    <time_frame>H48</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Respiratory Distress Syndrome</condition>
  <condition>Hypercapnia</condition>
  <arm_group>
    <arm_group_label>noninvasive ventilation alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After validation of the inclusion and exclusion criteria, the patients include in this clinical trial will be randomized between the two arms of the study:&#xD;
Noninvasive ventilation alone&#xD;
Noninvasive ventilation associated with the DECAP CO2 device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>noninvasive ventilation associated with the DECAP CO2 device</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>After validation of the inclusion and exclusion criteria, the patients include in this clinical trial will be randomized between the two arms of the study:&#xD;
Noninvasive ventilation alone&#xD;
Noninvasive ventilation associated with the DECAP CO2 device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Extracorporeal CO2 removal device</intervention_name>
    <arm_group_label>noninvasive ventilation alone</arm_group_label>
    <arm_group_label>noninvasive ventilation associated with the DECAP CO2 device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Adult patient suffering from severe chronic respiratory failure&#xD;
&#xD;
          -  Chronic obstructive pulmonary disease : stage III&#xD;
&#xD;
          -  Hypercapnic respiratory decomposition&#xD;
&#xD;
          -  No anticipated directive with the treating physician, pulmonologist or his family.&#xD;
&#xD;
          -  Challenged for invasive ventilation by critical care doctor, emergency doctor or&#xD;
             pulmonologist ; due to the respiratory pathology severity or other (age, comorbidity)&#xD;
&#xD;
          -  Not challenged for a noninvasive ventilation&#xD;
&#xD;
          -  Failure of the noninvasive ventilation in intensive care unit (pH decrease due to&#xD;
             hypercapnia after 2 hours of noninvasive ventilation&#xD;
&#xD;
        Obtaining of the consent of the patient or the reliable person or the close relation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - Patients who made anticipated directives (decision of the patient to have no&#xD;
             tracheotomy, intubation, noninvasive ventilation)&#xD;
&#xD;
          -  Contraindication to heparin (active bleeding, Heparin-induced thrombocytopenia)&#xD;
&#xD;
          -  Patients &lt; 18 years and &gt; 90 years&#xD;
&#xD;
          -  Patients already included in another therapeutic trial&#xD;
&#xD;
          -  Pregnant woman or breast feeding&#xD;
&#xD;
          -  Legal incapacity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre LAUTRETTE</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick LACARIN</last_name>
    <phone>04 73 75 11 95</phone>
    <email>placarin@chu-clermontferrand.fr</email>
  </overall_contact>
  <verification_date>January 2013</verification_date>
  <study_first_submitted>January 7, 2013</study_first_submitted>
  <study_first_submitted_qc>January 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2013</study_first_posted>
  <last_update_submitted>January 21, 2013</last_update_submitted>
  <last_update_submitted_qc>January 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypercapnia</keyword>
  <keyword>Respiratory Distress Syndrome</keyword>
  <keyword>Extracorporeal CO2 remover</keyword>
  <keyword>Noninvasive ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

